Zusammenfassung
Die Prävention von Phantomschmerzen ist eine der größten, noch weitgehend ungelösten Herausforderungen in der perioperativen Medizin. Trotz vieler Studienbemühungen ist es in den letzten 30 Jahren kaum gelungen, über die Optimierung der postoperativen Schmerztherapie hinaus eine deutliche Reduktion der Phantomschmerzinzidenz zu erreichen. Auch aktuelle Studien zeigen, dass zumindest etwa 50 % der Patienten nach 6 Monaten einen Phantomschmerz entwickeln. Ein Ansatz könnte darin bestehen, multiple synergistische Interventionen zu kombinieren und als perioperatives Phantomschmerzmanagementbündel zusammenzufassen. Neben der Regionalanästhesie könnten NMDA-Antagonisten, Gabapentinoide, Antidepressiva sowie systemisches Lidocain eine Rolle spielen. Ziel dieser pharmakologischen Intervention ist die Modifikation der pathophysiologischen Veränderungen am peripheren Nerv und am Zentralnervensystem nach Amputation.
Abstract
Prevention of phantom limb pain is one of the biggest and still largely unsolved challenges in perioperative medicine. Despite many study efforts and optimization of postoperative pain treatment over the last 30 years, a significant reduction in the incidence of phantom limb pain has not been achieved. Current studies have also shown that at least 50% of patients develop phantom pain after 6 months. A possible approach could be to combine multiple synergistic interventions and implement them as a perioperative phantom pain management strategy bundle. In addition to regional anesthesia, NMDA antagonists, gabapentinoids, antidepressants and systemic lidocaine could play a relevant role. The aim of this pharmacological intervention was the modification of the pathophysiological changes in peripheral nerves and in the central nervous system after amputation.
Literatur
Bach S, Noreng MF, Tjellden NU (1988) Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumbar epidural blockade. Pain 33:297–301
Borghi B, D’addabbo M, Borghi R (2014) Can neural blocks prevent phantom limb pain? Pain Manag 4:261–266
Bornemann-Cimenti H, Wejbora M, Michaeli K et al (2016) The effects of minimal-dose versus low-dose S‑ketamine on opioid consumption, hyperalgesia, and postoperative delirium: a triple-blinded, randomized, active- and placebo-controlled clinical trial. Minerva Anestesiol 82:1069–1076
Bosanquet DC, Ambler GK, Waldron CA et al (2019) Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): results from a randomised controlled feasibility trial. BMJ Open. https://doi.org/10.1136/bmjopen-2019-029233
Bosanquet DC, Glasbey JC, Stimpson A et al (2015) Systematic review and meta-analysis of the efficacy of perineural local anaesthetic catheters after major lower limb amputation. Eur J Vasc Endovasc Surg 50:241–249
Brandt L, Adams HA, Hönemann C (2016) 170 years of ether anaesthesia—An epochal event with a long history. Anasth Intensivmed 57:607–620
Davis KD, Flor H, Greely HT et al (2017) Brain imaging tests for chronic pain: medical, legal and ethical issues and recommendations. Nat Rev Neurol 13:624–638
De Jong R, Shysh AJ (2018) Development of a multimodal analgesia protocol for Perioperative acute pain management for lower limb amputation. Pain Res Manag 2018:5237040. https://doi.org/10.1155/2018/5237040
Dertwinkel R, Heinrichs C, Senne I et al (2002) Prevention of severe phantom limb pain by perioperative administration of ketamine—an observational study. Acute Pain 4:9–13
Eichenberger U, Neff F, Sveticic G et al (2008) Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg 106:1265–1273 (table of contents)
Flor H, Elbert T, Knecht S et al (1995) Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature 375:482–484
Galova K (2011) Phantom limb pain prevention with the application of Ketamine. Eur J Pain Suppl 5:241
Grigoras A, Lee P, Sattar F et al (2012) Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain 28:567–572
Hayes C, Armstrong-Brown A, Burstal R (2004) Perioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: a randomized, controlled trial. Anaesth Intensive Care 32:330–338
Herminghaus A, Wachowiak M, Wilhelm W et al (2011) Intravenous administration of lidocaine for perioperative analgesia. Review and recommendations for practical usage. Anaesthesist 60:152–160
Jahangiri M, Jayatunga AP, Bradley JW et al (1994) Prevention of phantom pain after major lower limb amputation by epidural infusion of diamorphine, clonidine and bupivacaine. Ann R Coll Surg Engl 76:324–326
Karanikolas M, Aretha D, Tsolakis I et al (2011) Optimized perioperative analgesia reduces chronic phantom limb pain intensity, prevalence, and frequency: a prospective, randomized, clinical trial. Anesthesiology 114:1144–1154
Khan JS, Hodgson N, Choi S et al (2019) Perioperative pregabalin and Intraoperative lidocaine infusion to reduce persistent neuropathic pain after breast cancer surgery: a multicenter, factorial, randomized, controlled pilot trial. J Pain 20:980–993
Kroger K, Berg C, Santosa F et al (2017) Lower limb amputation in Germany. Dtsch Arztebl Int 114:130–136
Lambert A, Dashfield A, Cosgrove C et al (2001) Randomized prospective study comparing preoperative epidural and intraoperative perineural analgesia for the prevention of postoperative stump and phantom limb pain following major amputation. Reg Anesth Pain Med 26:316–321
Lirk P, Stadlbauer KH, Hollmann MW (2013) ESA Clinical Trials Network 2012: PLATA—Prevention of Phantom Limb Pain After Transtibial Amputation: randomised, double-blind, controlled, multicentre trial comparing optimised intravenous pain control versus optimised intravenous pain control plus regional anaesthesia. Eur J Anaesthesiol 30:202–204
Melzack R (1971) Phantom limb pain: implications for treatment of pathologic pain. Anesthesiology 35:409–419
Mousa SA, Shaqura M, Al-Madol M et al (2017) Accessibility of axonal G protein coupled mu-opioid receptors requires conceptual changes of axonal membrane targeting for pain modulation. J Control Release 268:352–363
Nikolajsen L, Finnerup NB, Kramp S et al (2006) A randomized study of the effects of gabapentin on postamputation pain. Anesthesiology 105:1008–1015
Nikolajsen L, Hansen CL, Nielsen J et al (1996) The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 67:69–77
Nikolajsen L, Ilkjaer S, Jensen TS (1998) Effect of preoperative extradural bupivacaine and morphine on stump sensation in lower limb amputees. Br J Anaesth 81:348–354
Noguchi S, Saito J, Nakai K et al (2019) Factors affecting phantom limb pain in patients undergoing amputation: retrospective study. J Anesth 33:216–220
Nystrom B, Hagbarth KE (1981) Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett 27:211–216
Pinzur MS, Garla PG, Pluth T et al (1996) Continuous postoperative infusion of a regional anesthetic after an amputation of the lower extremity. A randomized clinical trial. J Bone Joint Surg Am 78:1501–1505
Ryan SP, Dilallo M, Klement MR et al (2019) Transfemoral amputation following total knee arthroplasty: mortality and functional outcomes. Bone Joint J 101-B:221–226
Schafer M, Mousa SA, Shaqura M et al (2019) Background and current use of adjuvants for regional anesthesia : from research to evidence-based patient treatment. Anaesthesist 68:3–14
Schmidt S (2006) Der Einfluss der perioperativen systemischen Gabe von Ketamin auf die Entstehung chronischer Phantomschmerzen nach partieller Amputation der unteren Extremität. Martin-Luther-Universität Halle-Wittenberg, Halle
Shaqura M, Li X, Al-Khrasani M et al (2016) Membrane-bound glucocorticoid receptors on distinct nociceptive neurons as potential targets for pain control through rapid non-genomic effects. Neuropharmacology 111:1–13
Shaqura M, Li X, Al-Madol MA et al (2016) Acute mechanical sensitization of peripheral nociceptors by aldosterone through non-genomic activation of membrane bound mineralocorticoid receptors in naive rats. Neuropharmacology 107:251–261
Stubhaug A, Breivik H, Eide PK et al (1997) Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 41:1124–1132
Wang X, Yi Y, Tang D et al (2018) Gabapentin as an adjuvant therapy for prevention of acute phantom-limb pain in pediatric patients undergoing amputation for malignant bone tumors: a prospective double-blind randomized controlled trial. J Pain Symptom Manage 55:721–727
Zaki M, El-Din A, Al-Tohamy M et al (2010) Limb amputation in ancient Egyptians from old Kingdom. J Appl Sci Res 6:913–917
Ziegler-Graham K, Mackenzie EJ, Ephraim PL et al (2008) Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 89:422–429
Leitlinie 001 – 025 der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V., „Behandlung akuter perioperativer und posttraumatischer Schmerzen“ 2009
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Tafelski gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
S. Tafelski ist Mitglied des Wissenschaftlichen Arbeitskreises Wissenschaftlicher Nachwuchs (WAKWiN) der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin e. V. (DGAI), und das Minireview basiert auf einem Vortrag aus der wissenschaftlichen Sitzung des WAKWiN auf dem HAI 2018.
Rights and permissions
About this article
Cite this article
Tafelski, S. Perioperative Maßnahmen zur Prävention von Phantomschmerz: ein evidenzbasierter Ansatz zur Risikoreduktion. Anaesthesist 69, 665–671 (2020). https://doi.org/10.1007/s00101-020-00810-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-020-00810-w